#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma refractory Pseudoxanthoma elasticum Waldenstrom's macroglobulinaemia Macular telangiectasia Acromegaly Cold type haemolytic anaemia Cardiac sarcoidosis B-cell small lymphocytic lymphoma Diffuse large B-cell lymphoma recurrent Glioma Malignant glioma Hepatic cirrhosis Hypoxic-ischaemic encephalopathy Ventricular fibrillation Myotonia More trials…

    Learn about Rare Diseases

    Alexander disease – Treatment Leiomyosarcoma recurrent – Trials in Disease Burkitt’s lymphoma Turner’s syndrome – Treatment Paraneoplastic neurological syndrome Richter’s syndrome – Trials in Disease Crigler-Najjar syndrome – Treatment Glycogen storage disease type II – Basic Information Crigler-Najjar syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xanthum Gum Azd9550 Tacrolimus Doxycycline Petrelintide Etripamil Cefotaxime Ofloxacin Hydrochloride Specific Nucleic Acid Sna-Xfsb Bedaquiline Rozanolixizumab Arsenic Trioxide Bt-001 Povidone Nintedanib Izokibep Loperamide Hydrochloride Efzofitimod Telmisartan Pimavanserin Tartrate More therapies…

    Learn about Your Condition

    Phenylketonuria Scoliosis Meniere's disease Escherichia infection Cholecystitis acute Delirium Intestinal obstruction Double hit lymphoma Psoriasis Tympanic membrane perforation Perthes disease Endometrial stromal sarcoma Neurodevelopmental disorder Diabetic gastroparesis Affective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Rituximab and Cyclophosphamide in Patients with ANCA Vasculitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Cyclophosphamide
    • Rituximab
    The Netherlands

  • Study on Pre-Surgery Immunotherapy with Relatlimab, Anti-IL-8 mAb, and Ipilimumab for Early-Stage Colon Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Anti-Il-8 Human Monoclonal Antibody
    • Celecoxib
    • Relatlimab
    The Netherlands

  • Study on HPV Vaccine for Women with Vulvar HSIL: Evaluating the Effectiveness of Nonavalent HPV Vaccine in Preventing Recurrence of Vulvar High-Grade Lesions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the vulva
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    The Netherlands

  • Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Belgium Germany The Netherlands Spain

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    • Acute myocardial infarction
    Investigated Drugs:
    • Noradrenaline Tartrate
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study Comparing Quinidine and Verapamil for Patients with Short-Coupled Idiopathic Ventricular Fibrillation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ventricular fibrillation
    Investigated Drugs:
    • Verapamil
    The Netherlands

  • Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    The Netherlands

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Dexamethasone
    • Dexamethasone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Erythromycin Lactobionate
    • Oseltamivir
    • Roxithromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prolymphocytic leukaemia
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Alectinib
    • Dacomitinib
    • Erlotinib
    The Netherlands
Previous Page
1 2 3 4 5 6 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!